Brief: Io Biotech Announces 2022 Fourth-Quarter And Year-End Results
March 14 (Reuters) - IO Biotech Inc IOBT.O :
* IO BIOTECH ANNOUNCES 2022 FOURTH-QUARTER AND YEAR-END
RESULTS
* IO BIOTECH INC: CASH ON HAND IS EXPECTED TO SUPPORT
OPERATIONS
THROUGH Q3 OF 2024
* IO BIOTECH INC: NET LOSS FOR THREE MONTHS ENDED DECEMBER
31,
2022 WAS $20.1 MILLION, COMPARED TO $21.3 MILLION
Source text for Eikon: ID:nGNX2sDstR
Further company coverage: IOBT.O
((Reuters.Briefs@thomsonreuters.com;))